Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted BronchoscopyIntuitive SurgicalNot Yet RecruitingPhase 4
NCT07761351Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-...Intuitive Surgical
NCT07759739
Er:YAG Laser Versus Conventional Cavity Preparation in Children With Molar-Incisor HypomineralizationEge UniversityActive Not RecruitingNot Applicable
NCT07759739Active Not Recruiting
Not Applicable
Er:YAG Laser Versus Conventional Cavity Preparation in Children With Molar-Incis...Ege University
NCT07761455
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07761455Not Yet Recruiting
Not Applicable
Prophylactic IABP in Delayed-Presentation Anterior STEMIQilu Hospital of Shandong...
NCT07760623
Common Carotid Artery-Renal Artery-Femoral Artery Survey for HypertensionDejthidaNathaphongNot Yet Recruiting
NCT07760623Not Yet Recruiting
—
Common Carotid Artery-Renal Artery-Femoral Artery Survey for HypertensionDejthidaNathaphong
NCT07760259
Autologous Tenon's Capsule Autograft for Large and Recurrent Full-Thickness Macular HolesBenha UniversityCompletedNot Applicable
NCT07760259Completed
Not Applicable
Autologous Tenon's Capsule Autograft for Large and Recurrent Full-Thickness Macu...Benha University
NCT07760584
Reducing Anxiety During Virtual Reality Kayaking in Youth With Intellectual Disabilities.Poznan University of Physical EducationCompletedNot Applicable
NCT07760584Completed
Not Applicable
Reducing Anxiety During Virtual Reality Kayaking in Youth With Intellectual Disa...Poznan University of Phys...
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07761247
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye UniversityNot Yet RecruitingNot Applicable
NCT07761247Not Yet Recruiting
Not Applicable
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye University
NCT07759726
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab UniversityCompletedNot Applicable
NCT07759726Completed
Not Applicable
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab University
NCT07759791
Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Activities Following StrokeBruyère Health Research Institute.RecruitingNot Applicable
NCT07759791Recruiting
Not Applicable
Supporting Re-engagement in Life: Coaching to Enhance Participation in Valued Ac...Bruyère Health Research I...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07761325
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic ChemotherapySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 3
NCT07761325Not Yet Recruiting
Phase 3
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone...Sun Yat-Sen Memorial Hosp...
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary SyndromeMst.Sumyara KhatunCompletedNot Applicable
NCT07759518Completed
Not Applicable
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian St...Mst.Sumyara Khatun
NCT07760454
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple MyelomaUCARsgen Biotech LimitedNot Yet RecruitingPhase 1
NCT07760454Not Yet Recruiting
Phase 1
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple MyelomaUCARsgen Biotech Limited
NCT07760090
Motor Imagery Added to Robot-Assisted Hand Rehabilitation After StrokeUskudar UniversityNot Yet RecruitingNot Applicable
NCT07760090Not Yet Recruiting
Not Applicable
Motor Imagery Added to Robot-Assisted Hand Rehabilitation After StrokeUskudar University
NCT07760818
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)argenxNot Yet RecruitingPhase 2
NCT07760818Not Yet Recruiting
Phase 2
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's D...argenx
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 41 (5%)
Phase 31 (5%)
Phase 11 (5%)